3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
7
Breast Neoplasms
4
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Smoking
1
Patient Acceptance of Health Care
1
Motor Activity
1
Lymphoma
1
Lung Cancer Screening
1
Leukemia
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Depression
1
Death
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Cancer Patients
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiosurgery
50
Magnetic Resonance Spectroscopy
34
Temozolomide
28
Bevacizumab
24
pembrolizumab
23
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
Blood Specimen Collection
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Focus Groups
×
1 year
×
Clear all
No trials found.